Stockscreener 앱 받기
313.53
2.65%
-8.53
전일 마감가:
$322.06
열려 있는:
$322.82
하루 거래량:
150.18K
Relative Volume:
0.75
시가총액:
$8.46B
수익:
$2.58B
순이익/손실:
$-778.69M
주가수익비율:
-11.47
EPS:
-27.33
순현금흐름:
$223.75M
1주 성능:
-3.18%
1개월 성능:
+3.81%
6개월 성능:
+26.80%
1년 성능:
-8.98%
1일 변동 폭
$313.47
$322.82
1주일 범위
$313.47
$328.56
52주 변동 폭
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
BIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
313.53 | 8.69B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Blood Screening Market Outlook 2026-2033: Technological - openPR.com
Microfluidics Market to Reach US$ 73.97 Billion by 2032 at 12.6% - openPR.com
Revenue Check: How correlated is Bio Rad Laboratories Inc to the S P5002025 Macro Impact & Verified Trade Idea Suggestions - baoquankhu1.vn
DNA/RNA Extraction Kit Market to Reach US$ 6.9 Billion by 2032 - openPR.com
SG Americas Securities LLC Buys 5,600 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Fund Flows: Can RF Acquisition Corp II Debt Equity Composite Units ride the EV waveMarket Trend Report & Expert Verified Movement Alerts - baoquankhu1.vn
DNA Extraction Kits Market Growth Outlook: Booming - openPR.com
Laboratory Equipment and Disposables Market is expected - openPR.com
Surprises Report: Will Bio Rad Laboratories Inc stock maintain growth story - Bộ Nội Vụ
Income Plays: What drives Bio Rad Laboratories Incs stock price2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
Why retail investors pile into Bio Rad Laboratories Inc stock2025 Winners & Losers & Fast Moving Trade Plans - Bộ Nội Vụ
Entry Recap: Can Bio Rad Laboratories Inc Class stock surprise with quarterly resultsMarket Weekly Review & Weekly Top Gainers Trade List - Bộ Nội Vụ
Epigenetics Market Booming with Rapid Growth Through 2033 | F. - openPR.com
Will Bio Rad Laboratories Inc. stock recover faster than marketJuly 2025 Reactions & Reliable Volume Spike Trade Alerts - Улправда
Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed actionJuly 2025 PreEarnings & Consistent Growth Stock Picks - Улправда
(BIO) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Bio Rad Laboratories Inc. stock appeals to analystsLong Run Comfort Guide & quick comparison of popular models - Улправда
Protein engineering market is set for steady growth to reach US$ - openPR.com
What insider trading reveals about Bio Rad Laboratories Inc. stockGap Up & Safe Entry Trade Reports - Улправда
Why Bio Rad Laboratories Inc. stock is trending among retail tradersOptions Play & Daily Momentum Trading Reports - Улправда
What analyst consensus says on Bio Rad Laboratories Inc. stockJuly 2025 Final Week & Consistent Growth Equity Picks - Улправда
Is Bio Rad Laboratories Inc. stock resilient to inflationMarket Growth Report & Consistent Growth Stock Picks - Улправда
Published on: 2026-01-09 02:49:47 - Улправда
Will Bio Rad Laboratories Inc. (BUW) stock enhance shareholder valueMarket Performance Recap & Intraday High Probability Alerts - Улправда
How Bio Rad Laboratories Inc. Class B stock gains from tech spendingQuarterly Trade Report & Technical Confirmation Trade Alerts - Улправда
Published on: 2026-01-09 02:16:09 - Улправда
What margin trends mean for Bio Rad Laboratories Inc. stockWall Street Watch & AI Powered Market Trend Analysis - Улправда
Is Bio Rad Laboratories Inc. Class B stock attractive for growth fundsJuly 2025 Price Swings & Weekly High Momentum Picks - Улправда
Published on: 2026-01-08 22:32:57 - Улправда
Is Bio Rad Laboratories Inc. stock a smart buy before Fed meetingJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - Улправда
Can Bio Rad Laboratories Inc. stock sustain institutional interest2025 Price Momentum & High Accuracy Investment Signals - ulpravda.ru
Can Bio Rad Laboratories Inc. stock beat market expectations this quarter2025 Market WrapUp & Intraday High Probability Alerts - Улправда
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above 50-Day Moving AverageHere's What Happened - MarketBeat
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
Laboratory Supplies Market 2026 Forecast: In-Depth Industry - openPR.com
Sivik Global Healthcare LLC Sells 7,000 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Basic Statistics in Laboratory Quality Control - Labroots
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference - BioSpace
United States In-vitro Cancer Diagnostics Market 2025 | Lead - openPR.com
Earnings Risk: Can Bio Rad Laboratories Inc stock beat market expectations this quarterJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - moha.gov.vn
Bio-Rad Laboratories, Inc. $BIO Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Helicobacter Pylori Diagnostics Market Forecast Through - openPR.com
Sample Preparation Market 2025 Forecast: In-Depth Industry - openPR.com
Boston Trust Walden Corp Invests $26.76 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Responsive Playbooks and the BIO Inflection - Stock Traders Daily
Marathon Asset Management Ltd Sells 7,893 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein A Resin Market is expected to reach US$ 4.1 billion by 2032 - openPR.com
Newborn Screening Market Assessment 2032: Segment Analysis, - openPR.com
Japan's Life Sciences Research and Clinical Applications Fuel - openPR.com
BIO (Bio-Rad Laboratories) Sale Of Property, Plant, Equipme - GuruFocus
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):